Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15307047rdf:typepubmed:Citationlld:pubmed
pubmed-article:15307047lifeskim:mentionsumls-concept:C0035235lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0024115lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0017968lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0672596lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0002518lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:15307047lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:15307047pubmed:issue2lld:pubmed
pubmed-article:15307047pubmed:dateCreated2004-8-12lld:pubmed
pubmed-article:15307047pubmed:abstractTextA patient with respiratory syncytial virus (RSV) infection and severe combined immunodeficiency was studied during a 3-month period of bone marrow transplantation and palivizumab infusion. No RSV isolates with palivizumab escape mutations were identified. Donor lymphocytes, including CD8 cells, appeared to markedly reduce the RSV load but increased the pulmonary symptoms. Immunosuppressive therapy ameliorated lung disease but allowed the RSV load to rebound.lld:pubmed
pubmed-article:15307047pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:languageenglld:pubmed
pubmed-article:15307047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:citationSubsetIMlld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15307047pubmed:statusMEDLINElld:pubmed
pubmed-article:15307047pubmed:monthJullld:pubmed
pubmed-article:15307047pubmed:issn1537-6591lld:pubmed
pubmed-article:15307047pubmed:authorpubmed-author:ConleyM EMElld:pubmed
pubmed-article:15307047pubmed:authorpubmed-author:DeVincenzoJ...lld:pubmed
pubmed-article:15307047pubmed:authorpubmed-author:El SaleebyC...lld:pubmed
pubmed-article:15307047pubmed:authorpubmed-author:SuzichJJlld:pubmed
pubmed-article:15307047pubmed:issnTypeElectroniclld:pubmed
pubmed-article:15307047pubmed:day15lld:pubmed
pubmed-article:15307047pubmed:volume39lld:pubmed
pubmed-article:15307047pubmed:ownerNLMlld:pubmed
pubmed-article:15307047pubmed:authorsCompleteYlld:pubmed
pubmed-article:15307047pubmed:paginatione17-20lld:pubmed
pubmed-article:15307047pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:meshHeadingpubmed-meshheading:15307047...lld:pubmed
pubmed-article:15307047pubmed:year2004lld:pubmed
pubmed-article:15307047pubmed:articleTitleQuantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.lld:pubmed
pubmed-article:15307047pubmed:affiliationDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. chadi.elsaleeby@stjude.orglld:pubmed
pubmed-article:15307047pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15307047pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15307047pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:15307047pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15307047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15307047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15307047lld:pubmed